medigraphic.com
Órgano Oficial de la Asociación Mexicana de Hepatología

2009, Number 1

<< Back Next >>

Ann Hepatol 2009; 8 (1)

Autoimmune hepatitis with giant-cell transformation

Estradas J, Pascual-Ramos V, Martínez B, Uribe M, Torre A

Language: Spanish
References: 20
Page: 68-70
PDF size: 149.03 Kb.


Text Extraction

Background/Aims: Giant-cell hepatitis (GCH), also known as postinfantile or syncytial giant cell hepatitis, is a frequent pattern of liver injury in the neonate, primarily seen in the first three months of life. Few cases in adults have been reported, some of them associated to autoimmune diseases such as autoimmune hepatitis. Methods: We present a case of autoimmune hepatitis with giant cell transformation in a 39 year old male with polyarthritis. We discuss his clinical presentation and course. We made a review of the literature of agents associated to this diagnosis, the mechanisms involved in the formation of giant hepatocytes, the histological findings, clinical course, treatment options and prognosis of this rare entity. Results and conclusions: In conclusion, the clinical course varies from normalization of hepatic histology to progression to cirrhosis and liver failure. The prognosis is dictated by the underlying liver disease and in the setting of autoimmune hepatitis the clinical course is usually severe with most of the patients progressing to cirrhosis. Prolonged treatment with corticosteroids and immunosuppressants is usually effective in rendering the cirrhosis inactive.


REFERENCES

  1. Alvarez F, Berg PA, Bianchi FB, Bianchi L, Burroughs AK, Cancado EL, et al. International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol 1999; 31: 929-38.

  2. Labowitz J, Finklestein S, Rabinovitz M. Postinfantile giant cell hepatitis complicating ulcerative colitis: a case report and review of the literature. Am J Gastroenterol 2001; 96: 1274-7.

  3. Protzer U, Dienes HP, Bianchi L, Lohse AW, Helmreich-Becker I, Gerken G, Meyer zum Buschenfelde KH. Post-infantile giant cell hepatitis in patients with primary sclerosing cholangitis and autoimmune hepatitis. Liver 1996; 16: 274-82.

  4. Devaney K, Goodman ZD, Ishak KG. Postinfantile giant-cell transformation in hepatitis. Hepatology 1992; 16: 327-33.

  5. Ben-Ari Z, Broida E, Monseliese Y, Kazatsker A, Baruch J, Pappo O, et al. Syncytial giant-cell hepatitis due to autoimmune hepatitis type II (LKM1+) presenting as subfulminant hepatitis. Am J Gastroenterol 2000; 95: 799-801.

  6. Kryczka W, Walewska-Zielecka B, Dutkiewicz E. Acute seronegative hepatitis C manifesting itself as adult giant cell hepatitis –a case report and review of literature. Med Sci Monit 2003; 9 Suppl 3: 29-31.

  7. Philips MJ, Blendis LM, Poucell S, offterson J, Petric M, Roberts E, et al. Syncitial giant-cell hepatitis. Sporadic hepatitis with distinctive pathological features, a severe clinical course, and paramyxomal features. N Eng J Med 1991; 324: 455-60.

  8. Kuntzen T, Friedrichs N, Fischer HP, Eis-Hübinger AM, Sauerbruch T, Spengler U. Postinfantile giant cell hepatitis with autoimmune features following a human herpesvirus 6-induced adverse reaction. Eur J Gastroenterol Hepatol 2005; 17: 1131-4.

  9. Alexopoulou A, Deutsch M, Ageletopoulou J, Delladetsima JK, Marinos E, Kapranos N, et al. A fatal case of postinfantile giant cell hepatitis with chronic lymphocytic leukaemia. Eur J Gastroenterol Hepatol 2003; 15: 551-5.

  10. Koskinas J, Deutsch M, Papaioannou C, Kafiri G, Hadzivannis S. Post-infantile giant cell hepatitis associated with autoimmune hepatitis and polyarteritis nodosa. Sand J Gastroenterol 2002; 37: 120-3.

  11. Scheuer PJ, Lefkowitch JH. Chronic hepatitis. In: WB Saunders, eds. Liver Biopsy Interpretation. 6th ed. London, 2000: 164-166.

  12. Anagnostopoulos GK, Margantinis G, Tsiakos S, Kostopoulos P, Grigoriadis K, Arvantidis D. Postinfantile giant-cell hepatitis associated with ulcerative colitis and autoimmune hepatitis. J Gastroenterol Hepatol 2006; 21: 1863-4.

  13. Watanabe N, Takashimizu S, Shiraishi K, Kagawa T, Nishizaki Y, Mine T, et al. Primary biliary cirrhosis with multinucleated hepatocelular giant cells: implications for pathogenesis of primary biliary cirrhosis. Eur J Gastroenterol Hepatol 2006; 18: 1023-7.

  14. Lau JY, Koukoulis G, Mieli-Vergani G, Portmann BC, Williams R. Syncytial giant-cell hepatitis - a specific disease entity? J Hepatol 1992; 15: 216-19.

  15. Thaler H. Post-infantile giant cell hepatitis. Liver 1982; 2: 393-403.

  16. Tordjmann T, Grimbert S, Genestie C, Freymuth F, Guettier C, Callard P, et al. [Adult multi-nuclear hepatitis. A study in 17 patients]. Gastroenterol Clin Biol 1998; 22: 305-10.

  17. Pittau S, Morelli S, Venturini E, Boldorini R, Sartoi M. [Post-infantile giant cell hepatitis. Clinical and histological response to immunosuppressive therapy]. Recenti Prog Med 1998; 89: 126-9.

  18. Erolu Y, Düzovali O, Kavucku S, Irken G, Büyükgebiz B. Combination of steroid with azathioprine in treatment of giant cell autoimmune hepatitis. Turk J Pediatr 1997; 39: 565-71.

  19. Pappo O, Yunis E, Jordan JA, Jaffe R, Mateo R, Fung J, et al. Recurrent and de novo giant cell hepatitis after orthotopic liver transplantation. Am Surg Pathol 1994; 18: 804-13.

  20. Shah JA, Steinbrecher UP, Erb SR, Tha SP, Yoshida EM. Recurrent giant cell hepatitis in an 18 year old liver transplant patient. Ann Hepatol 2008; 7: 257.




2020     |     www.medigraphic.com